STIFEL FINANCIAL CORP - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 178 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$876,000
+327.3%
87,728
+1193.5%
0.00%
+100.0%
Q4 2015$205,000
-58.2%
6,782
-45.0%
0.00%
-66.7%
Q3 2015$490,000
-88.6%
12,338
-80.2%
0.00%
-72.7%
Q2 2015$4,298,00062,2420.01%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,344,620$116,393,0006.64%
Consonance Capital Management LP 1,026,902$35,736,0003.92%
FALCON POINT CAPITAL, LLC 801,944$27,908,0003.74%
Credit Capital Investments LLC 72,813$2,534,0003.24%
Crosspoint Capital Strategies, LLC 99,274$3,455,0003.07%
Camber Capital Management LP 611,390$21,276,0001.11%
IRONWOOD INVESTMENT MANAGEMENT LLC 40,901$1,423,0001.04%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 344,103$11,974,0000.83%
STELLIAM INVESTMENT MANAGEMENT, LP 572,500$19,923,0000.66%
AlphaOne Investment Services, LLC 66,105$2,301,0000.64%
View complete list of AMAG PHARMACEUTICALS INC shareholders